Literature DB >> 13584851

Jaundice associated with administration of iproniazid; report of two cases.

S BENAIM, M F DIXON.   

Abstract

Entities:  

Keywords:  DEPRESSION/therapy; JAUNDICE/etiology and pathogenesis; NICOTINIC ACID ISOMERS/injurious effects

Mesh：

Substances：

Year:  1958        PMID： 13584851      PMCID： PMC2026817          DOI： 10.1136/bmj.2.5104.1068

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  10 in total

1.  Fatal toxic encephalitis occurring during iproniazid therapy in pulmonary tuberculosis.

Authors:  R S MITCHELL
Journal:  Ann Intern Med       Date:  1955-02       Impact factor: 25.391

2.  Toxic effects of iproniazid in a patient with angina.

Authors:  C PAPP; S BENAIM
Journal:  Br Med J       Date:  1958-11-01

3.  Biochemical findings relating to the action of serotonin.

Authors:  S UDENFRIEND; H WEISSBACH; D F BOGDANSKI
Journal:  Ann N Y Acad Sci       Date:  1957-03-14       Impact factor: 5.691

4.  Therapeutic trial of iproniazid (marsilid) in depressed and apathetic patients.

Authors:  R L DEVERTEUIL; H E LEHMANN
Journal:  Can Med Assoc J       Date:  1958-01-15       Impact factor: 8.262

5.  Allergy to chlorpromazine manifested by jaundice.

Authors:  L E HOLLISTER
Journal:  Am J Med       Date:  1957-12       Impact factor: 4.965

6.  Toxicology of marsilid.

Authors:  L O RANDALL
Journal:  J Clin Exp Psychopathol       Date:  1958 Apr-Jun

7.  On the mechanism of drug potentiation by iproniazid (2-isopropyl-1-isonicotinyl hydrazine).

Authors:  J R FOUTS; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1956-04       Impact factor: 4.030

8.  The treatment of pulmonary tuberculosis with iproniazid (1-isonicotinyl-2-isopropyl hydrazine) and isoniazid (isonicotinyl hydrazine).

Authors:  C M OGILVIE
Journal:  Q J Med       Date:  1955-04

9.  Jaundice associated with the administration of chlorpromazine, SKF-2601-A (thorazine); report of three cases, with biopsies of the liver.

Authors:  E R MOVITT; M A MEYER; A M SNELL; M J GOLDMAN; J R GIBSON; B H SULLIVAN; J G WEBSTER; R B STONE
Journal:  Gastroenterology       Date:  1955-06       Impact factor: 22.682

10.  Toxicity to iproniazid (marsilid) as it affects osseous tuberculosis.

Authors:  D M BOSWORTH; J W FIELDING; L DEMAREST; M BONAQUIST
Journal:  Sea View Hosp Bull       Date:  1955-01
  10 in total
  7 in total

1.  Effects of iproniazid in depressive syndromes.

Authors:  E D WEST; P J DALLY
Journal:  Br Med J       Date:  1959-06-13

2.  Jaundice following iproniazid administration with recovery; serial biochemical and histological observations of two patients.

Authors:  S P BRALOW; H SHAY
Journal:  Am J Dig Dis       Date:  1959-12

3.  IPRONIAZID in angina pectoris.

Authors: 
Journal:  Can Med Assoc J       Date:  1959-01-15       Impact factor: 8.262

4.  DRUGS and liver disease.

Authors: 
Journal:  Br Med J       Date:  1958-11-08

5.  Dangerous potentiation of pethidine by iproniazid, and its treatment.

Authors:  J C SHEE
Journal:  Br Med J       Date:  1960-08-13

6.  Preliminary observations on cavodil in treatment of angina pectoris.

Authors:  J MACKINNON; D E ANDERSON; G HOWITT
Journal:  Br Med J       Date:  1960-01-23

7.  Hepatic Necrosis Due to Marsilid.

Authors:  C F McCarthy; M R Sheridan
Journal:  Gut       Date:  1960-06       Impact factor: 23.059
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.